Basilea Pharmaceutica Deutschland GmbH

http://www.basilea.com

	Start	2011-04-16 existent
	Group	Basilea (Group)
	Industry	pharmaceutical

	Region	München (Munich)
	Country	Germany
	Street	75 Kistlerhofstr.
	City	81379 München
	Tel	+49-89-7857-6740
	Fax	+49-89-7857-674100
		Address record changed: 2011-04-16

Basic data	Employees	n. a.


		Record changed: 2012-02-25

More documents for Basilea (Group)

[1] Basilea Pharmaceutica Ltd.. (12/14/12). "Press Release: Basilea Reports Recruitment Completion of Phase 3 Pivotal Study of Isavuconazole, an Agent for the Potential Primary Treatment of Invasive and Life-threatening Fungal Infections". Basel....
[2] Basilea Pharmaceutica Ltd.. (12/10/12). "Press Release: Basilea Appoints Ronald Scott as CEO to Succeed Anthony Man and Expands Management Team". Basel....
[3] Uniqure B.V.. (12/6/12). "Press Release: Uniqure Appoints Hans Christian Rohde Chief Commercial Officer". Amsterdam....
[4] Basilea Pharmaceutica Ltd.. (11/22/12). "Press Release: Basilea Initiates Next Phase 1 Multiple Ascending Dose Study with Antibiotic BAL30072 Active against Multidrug-resistant Gram-negative Bacteria". Basel....
[5] Basilea Pharmaceutica Ltd.. (8/16/12). "Press Release: Basilea Reports Its Half-year Results". Basel....
[6] Basilea Pharmaceutica Ltd.. (7/30/12). "Press Release: Basilea Submits European Marketing Authorization Application of Ceftobiprole for the Treatment of Pneumonia". Basel....
[7] Basilea Pharmaceutica Ltd.. (7/23/12). "Press Release: Basilea Announces Completion of Toctino (alitretinoin) Transaction with Stiefel. Basilea Receives GBP 146 Million (approximately CHF 225 Million) Upfront Payment". Basel....
[8] Basilea Pharmaceutica Ltd.. (6/11/12). "Press Release: Basilea Enters into Global Agreement with Stiefel, a GSK Company, for Toctino (alitretinoin). Stiefel Gains Exclusive Worldwide Rights to Toctino (altitretonin) and Assumes Toctino Distribution Agree...
[9] Basilea Pharmaceutica Ltd.. (5/25/12). "Press Release: Basilea Participates in Public-private Collaboration to Tackle Antibiotic Resistance". Basel....
[10] Basilea Pharmaceutica Ltd.. (3/12/12). "Press Release: Basilea’s U.S. Phase III HANDEL Study with Investigational Compound Oral Alitretinoin Meets Study Endpoints". Basel....

To subscribe to our free, monthly newsletter for the life sciences in German-speaking Europe (DE, AT & CH), please send an e-mail to info@iito.de and simply fill the subject line with the word »LSG newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

» top

Top News

Upcoming Events

Bio Regions & Life Sciences Clusters

Business Parks & Science Centres

Associations

Partners

Basilea Pharmaceutica Deutschland GmbH

More documents for Basilea (Group)